The metabolic fate of izencitinib, a gut-selective pan-JAK inhibitor, in humans. Identification of unusual fecal metabolites and implications for MIST evaluation von Yeola, Suresh, Badagnani, Ilaria, Huang, Xiaojun, Segraves, Nathanial L., Rapta, Miroslav, Borin, Marie T., Obedencio, Glenmar P., Fitch, William L., Baillie, Thomas A., Bourdet, David L.

Volltext